Systemic therapy for triple-negative breast cancer: A changing landscape. (March 2022)
- Record Type:
- Journal Article
- Title:
- Systemic therapy for triple-negative breast cancer: A changing landscape. (March 2022)
- Main Title:
- Systemic therapy for triple-negative breast cancer: A changing landscape
- Authors:
- Kessler, Alaina J.
Sparano, Joseph A. - Abstract:
- Highlights: Within the last year, several therapeutic strategies have been shown to improve survival outcomes in patients with localized or metastatic TNBC. Newly approved agents include pembrolizumab, olaparib, and sacituzumab govitecan. The approval of these treatments raises several questions regarding optimizing the clinical application of the new options.
- Is Part Of:
- Critical reviews in oncology/hematology. Volume 171(2022)
- Journal:
- Critical reviews in oncology/hematology
- Issue:
- Volume 171(2022)
- Issue Display:
- Volume 171, Issue 2022 (2022)
- Year:
- 2022
- Volume:
- 171
- Issue:
- 2022
- Issue Sort Value:
- 2022-0171-2022-0000
- Page Start:
- Page End:
- Publication Date:
- 2022-03
- Subjects:
- Oncology -- Periodicals
Hematology -- Periodicals
616.994 - Journal URLs:
- http://www.sciencedirect.com/science/journal/10408428 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.critrevonc.2022.103608 ↗
- Languages:
- English
- ISSNs:
- 1040-8428
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3487.479000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 21061.xml